TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8151606

Group type: EXPERIMENTAL
Intervention: Low sodium (80 mmol/day) with fish oil (5 g of omega-3 fatty acids per day)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Normal sodium (150 mmol/day) with fish oil
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Low sodium with olive oil
Number of subjects: 56

Group type: COMPARATOR
Intervention: Normal sodium with olive oil
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Sodium restriction
Number of subjects: 56
Study: 2470358

Group type: EXPERIMENTAL
Intervention: Iloprost (less than or equal to 2ng/kg/min)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 31615294

Group type: EXPERIMENTAL
Intervention: Low health literacy
Number of subjects: 3459
Study: 30714216

Group type: EXPERIMENTAL
Intervention: 8-mm diameter fully covered self-expandable metal stent (FCSEMS)
Number of subjects: 202

Group type: COMPARATOR
Intervention: 10-mm diameter fully covered self-expandable metal stent (FCSEMS)
Number of subjects: 202
Study: 28115007

Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 300

Group type: COMPARATOR
Intervention: Home-based exercise education (Control)
Number of subjects: 300
Study: 26894151

Group type: EXPERIMENTAL
Intervention: Fentanyl 1 μg/kg + bupivacaine local infiltration + Dexemedetomidine infusion (Loading 0.5 μg/kg, Maintenance 0.2μg/kg/hr)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Fentanyl 1 μg/kg + bupivacaine local infiltration
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fentanyl 1 μg/kg
Number of subjects: 90
Study: 24205786

Group type: EXPERIMENTAL
Intervention: Complementary therapy (CT)
Number of subjects: 32
Study: 22124142

Group type: COMPARATOR
Intervention: TMS(CT)
Number of subjects: 8

Group type: COMPARATOR
Intervention: SAS
Number of subjects: 8

Group type: COMPARATOR
Intervention: TMS(SAS)
Number of subjects: 8

Group type: COMPARATOR
Intervention: TMS+SAS
Number of subjects: 8
Study: 19701925

Group type: EXPERIMENTAL
Intervention: Clozapine with regular blood testing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparator treatments with limited blood testing
Number of subjects: 0
Study: 17718365

Group type: EXPERIMENTAL
Intervention: Exploration strategy 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exploration strategy 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased angular extent from 20 degrees to 135 degrees
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local apex information
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Depiction mode
Number of subjects: 0
Study: 15562017

Group type: EXPERIMENTAL
Intervention: Estradiol and inhibin secretion from ovarian follicles
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Follicular development in POF women
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: FSH levels in POF women
Number of subjects: 49

Group type: COMPARATOR
Intervention: Comparison of FSH levels
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Inhibin levels in relation to FSH
Number of subjects: 49
Study: 12386042

Group type: EXPERIMENTAL
Intervention: Case method learning dialogues facilitated by a cardiologist
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control group (conventional presentation of practice guidelines)
Number of subjects: 255
Study: 10639657

Group type: EXPERIMENTAL
Intervention: Chronic Achilles tendinosis
Number of subjects: 9

Group type: COMPARATOR
Intervention: Normal Achilles tendons
Number of subjects: 9
Study: 7797651

Group type: EXPERIMENTAL
Intervention: Meditation plus PHEP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PHEP only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 2309645

Group type: EXPERIMENTAL
Intervention: Mackerel paste (135 g daily)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Meat paste (control group)
Number of subjects: 42
Study: 391240

Group type: EXPERIMENTAL
Intervention: Cetraxate (CET) hydrochloride
Number of subjects: 234

Group type: COMPARATOR
Intervention: Gefarnate (control)
Number of subjects: 234
Study: 31599661

Group type: EXPERIMENTAL
Intervention: Snack at Night (SN; n = 13)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Meal at Night (MN; n= 12)
Number of subjects: 39

Group type: COMPARATOR
Intervention: No Eating at Night (NE; n = 14)
Number of subjects: 39
Study: 27545497

Group type: EXPERIMENTAL
Intervention: TDF 300mg once daily
Number of subjects: 280

Group type: COMPARATOR
Intervention: FTC 200mg and TDF 300mg once daily
Number of subjects: 280
Study: 26049257

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1 mA, 13 min, on the motor primary cortex) applied before training
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied during training
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied after training
Number of subjects: 12
Study: 25143985

Group type: EXPERIMENTAL
Intervention: Electrocautery for coagulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonintervention group
Number of subjects: 0
Study: 22168961

Group type: EXPERIMENTAL
Intervention: Nebulized fentanyl citrate (50 mcg)
Number of subjects: 12
Study: 19544820

Group type: EXPERIMENTAL
Intervention: Flowable composite (Flowable Filtek Supreme XT) or flowable composite (Dyract Flow) as gingival liners
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Packable composite (Filtek P60) or nano‐filled composite (Universal Filtek Supreme XT) with flowable liners
Number of subjects: 144

Group type: COMPARATOR
Intervention: Light curing technology (LED)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Light curing technology (QTH)
Number of subjects: 144
Study: 17949629

Group type: EXPERIMENTAL
Intervention: Intensive monitoring of cardiovascular risk (CVR) factors
Number of subjects: 188

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 188
Study: 15346266

Group type: EXPERIMENTAL
Intervention: PTA
Number of subjects: 124

Group type: COMPARATOR
Intervention: Palmaz stent placement
Number of subjects: 124
Study: 11748333

Group type: EXPERIMENTAL
Intervention: Population-based random sample reference range
Number of subjects: 484

Group type: COMPARATOR
Intervention: Unselected volunteers reference range
Number of subjects: 484

Group type: COMPARATOR
Intervention: Selected healthy subset reference range
Number of subjects: 484
Study: 11913408

Group type: EXPERIMENTAL
Intervention: Continuous conjugated equine estrogens (CE) + continuous medroxyprogesterone acetate (MPA) 2.5 mg (Group A)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Continuous conjugated equine estrogens (CE) + continuous medroxyprogesterone acetate (MPA) 5 mg (Group B)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (Group E)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Continuous medroxyprogesterone acetate (MPA) 5 mg (Group C)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Continuous medroxyprogesterone acetate (MPA) 10 mg (Group D)
Number of subjects: 100
Study: 7547078

Group type: EXPERIMENTAL
Intervention: Recombinant IFN alpha‐2b (3 x 10(6) IU 3 times weekly)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 150
Study: 2675757

Group type: EXPERIMENTAL
Intervention: Norfloxacin (800 mg single dose)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (5-day treatment)
Number of subjects: 55
Study: 26369

Group type: EXPERIMENTAL
Intervention: Suxamethonium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fazadinium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pancuronium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tubocurarine
Number of subjects: 0
Study: 30626566

Group type: EXPERIMENTAL
Intervention: mHealth app (app-only)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: mHealth app plus physical activity tracker and digital scale (app-plus)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Information-only control group
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: All participants
Number of subjects: 244
Study: 26746219

Group type: EXPERIMENTAL
Intervention: Dietary guidelines compliance
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control diet (traditional British diet)
Number of subjects: 165
Study: 26650491

Group type: EXPERIMENTAL
Intervention: 1.8 mL of 2% lidocaine for inferior alveolar nerve block (IANB)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control group (mild preoperative pain)
Number of subjects: 177
Study: 23645690

Group type: EXPERIMENTAL
Intervention: CHVP-interferon plus rituximab
Number of subjects: 358

Group type: COMPARATOR
Intervention: CHVP-interferon
Number of subjects: 358
Study: 16413328

Group type: EXPERIMENTAL
Intervention: Alfuzosin 10 mg once daily for 4 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 15072886

Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 2802

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2802
Study: 10813541

Group type: COMPARATOR
Intervention: 7 L leukapheresis
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 10 L leukapheresis
Number of subjects: 60
Study: 8856576

Group type: EXPERIMENTAL
Intervention: Amino acids (L-alanine, L-glutamine, L-phenylalanine, L-proline)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Glucose
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: L-alanine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Acarbose pretreatment
Number of subjects: 15
Study: 1478771

Group type: EXPERIMENTAL
Intervention: Active treatment for 70 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham treatment for 36 weeks followed by active treatment for 30 weeks (crossover group)
Number of subjects: 27
Study: 6143669

Group type: EXPERIMENTAL
Intervention: 20 mg zetidoline
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30586704

Group type: EXPERIMENTAL
Intervention: Permanent polymer zotarolimus-eluting stent (PP-ZES)
Number of subjects: 1502

Group type: COMPARATOR
Intervention: Polymer-free amphilimus-eluting stent (PF-AES)
Number of subjects: 1502
Study: 29332068

Group type: EXPERIMENTAL
Intervention: Transtympanic steroids (0.5 mL of 10 mg/mL dexamethasone at 24 h prior to surgery)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oral steroids (1 mg/kg/day of prednisolone for 6 days prior to surgery)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no steroids)
Number of subjects: 30
Study: 26198842

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Galactose
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard medical therapy (lisinopril, losartan, atorvastatin)
Number of subjects: 21
Study: 23599045

Group type: EXPERIMENTAL
Intervention: GLP-1 (7-36 amide) infusion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 30
Study: 21719866

Group type: EXPERIMENTAL
Intervention: HQ system (cleanser, toner, proprietary 4% hydroquinone, exfoliant, and sunscreen) plus 0.05% tretinoin cream
Number of subjects: 61

Group type: COMPARATOR
Intervention: Standard skin care regimen (cleanser, moisturizer, and sunscreen)
Number of subjects: 61
Study: 19423530

Group type: EXPERIMENTAL
Intervention: Estrogen-alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin
Number of subjects: 0
Study: 16467415

Group type: EXPERIMENTAL
Intervention: Higher mean summer temperature (1.3 degrees C increase)
Number of subjects: 3964

Group type: EXPERIMENTAL
Intervention: Higher mean summer rainfall (33.9 mm increase)
Number of subjects: 3964
Study: 15071274

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 103

Group type: COMPARATOR
Intervention: ICD
Number of subjects: 103
Study: 10857374

Group type: EXPERIMENTAL
Intervention: Polarized light exposure
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nonpolarized light exposure
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control, dark exposure
Number of subjects: 6
Study: 8557151

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) 100 mg daily
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (one tablet daily)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Goserelin acetate 3.6 mg (Zoladex depot)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: MPA
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 1614351

Group type: EXPERIMENTAL
Intervention: Educational intervention between presentations 1 and 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Educational intervention between presentations 2 and 3
Number of subjects: 0

Group type: COMPARATOR
Intervention: Repeated presentations alone (Control)
Number of subjects: 0
Study: 3903533

Group type: EXPERIMENTAL
Intervention: Naltrexone 25 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Naltrexone 0 mg (placebo)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Naltrexone 100 mg
Number of subjects: 10
Study: 30672317

Group type: EXPERIMENTAL
Intervention: Acupuncture (two sessions per week for three months)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Citicoline (100 mg three times daily for three months)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 216

Group type: COMPARATOR
Intervention: Citicoline
Number of subjects: 216

Group type: COMPARATOR
Intervention: Acupuncture and Citicoline
Number of subjects: 216
Study: 30027607

Group type: EXPERIMENTAL
Intervention: Exergaming (video gaming that involves physical activity) for 24 weeks, 1 hour per session, three times a week, with telehealth coaching.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group received exergames after the final clinic visit.
Number of subjects: 46
Study: 27306732

Group type: EXPERIMENTAL
Intervention: Executive function training focusing on inhibitory control (IC) and mindfulness integration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mindfulness training integrated with executive function skills training
Number of subjects: 0
Study: 24880524

Group type: EXPERIMENTAL
Intervention: Mindfulness based neuropsychological intervention
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control group (receiving donepezil)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Cognitive stimulation and progressive muscular relaxation (experimental groups)
Number of subjects: 127
Study: 21971720

Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy using the Solitaire stent
Number of subjects: 87

Group type: COMPARATOR
Intervention: Local intraarterial thrombolysis using urokinase
Number of subjects: 87
Study: 20501914

Group type: EXPERIMENTAL
Intervention: 15 online emergency preparedness training modules
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no training modules)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Confidence Survey
Number of subjects: 52
Study: 17715032

Group type: EXPERIMENTAL
Intervention: Preventive nodal irradiation (PNI) of the mediastinal lymph node drainage (Group A)
Number of subjects: 53

Group type: COMPARATOR
Intervention: No preventive nodal irradiation (Group B)
Number of subjects: 53
Study: 15668838

Group type: EXPERIMENTAL
Intervention: Birth preparation classes (8 sessions during pregnancy)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 200
Study: 12090385

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for hypochondriasis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for body dysmorphic disorder (BDD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for undifferentiated somatoform disorders
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy (CBT) for body dysmorphic disorder (BDD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy (CBT) for somatization disorder
Number of subjects: 0
Study: 10740418

Group type: EXPERIMENTAL
Intervention: Obese women (group 1)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Subgroup 1a (obese women with upper body obesity)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Healthy women (group 2)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Obese women
Number of subjects: 62
Study: 7861218

Group type: EXPERIMENTAL
Intervention: Collagen sponge
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control (no collagen sponge)
Number of subjects: 102
Study: 1773485

Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 7021070

Group type: EXPERIMENTAL
Intervention: 200 mg flurbiprofen daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: 4.0 g enteric-coated aspirin daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison between flurbiprofen and enteric-coated aspirin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Side effects reported for aspirin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Side effects reported for flurbiprofen
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Blood urea levels
Number of subjects: 40
Study: 31563881

Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg/mL
Number of subjects: 170

Group type: COMPARATOR
Intervention: Saline 0.9%
Number of subjects: 170
Study: 28378851

Group type: EXPERIMENTAL
Intervention: Standard diabetic diet enriched with EPA (120 mg) and DHA (616 mg) twice a day (Study group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard diabetic diet with placebo (Control group)
Number of subjects: 90
Study: 26413530

Group type: EXPERIMENTAL
Intervention: PbtO2-guided management (PbtO2 > 20 mmHg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: ICP-guided therapy (ICP < 20 mmHg and CPP > 60 mmHg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: PbtO2-guided management
Number of subjects: 50
Study: 24121408

Group type: EXPERIMENTAL
Intervention: High myopia group (15 children)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Low myopia group (20 children)
Number of subjects: 35
Study: 21175271

Group type: EXPERIMENTAL
Intervention: Sensor On
Number of subjects: 153

Group type: COMPARATOR
Intervention: Sensor Off
Number of subjects: 153
Study: 19135905

Group type: EXPERIMENTAL
Intervention: Move to Improve intervention
Number of subjects: 1442

Group type: COMPARATOR
Intervention: Health education control condition
Number of subjects: 1442
Study: 17212759

Group type: EXPERIMENTAL
Intervention: Physical education instruction
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Walking or bicycling to school
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Interscholastic sports
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intramural sports
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Programs for girls
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: After school free play
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Environmental support score
Number of subjects: 36

Group type: COMPARATOR
Intervention: Free/reduced lunch program participation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Perceived priority of physical education instruction over coaching
Number of subjects: 36

Group type: COMPARATOR
Intervention: Safety for walking/bicycling to school
Number of subjects: 36
Study: 15097262

Group type: EXPERIMENTAL
Intervention: Dorzolamide/Timolol fixed combination
Number of subjects: 492

Group type: COMPARATOR
Intervention: Brimonidine plus Timolol
Number of subjects: 492
Study: 11167641

Group type: EXPERIMENTAL
Intervention: Doxazosin GITS
Number of subjects: 1475

Group type: EXPERIMENTAL
Intervention: Doxazosin standard (S)
Number of subjects: 1475

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1475

Group type: EXPERIMENTAL
Intervention: Doxazosin GITS and Doxazosin standard (S)
Number of subjects: 1475
Study: 9270086

Group type: EXPERIMENTAL
Intervention: 5 mg felodipine daily for 3 months
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 10 mg felodipine daily for 3 months
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 5 mg felodipine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 10 mg felodipine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Felodipine treatment
Number of subjects: 16
Study: 7910871

Group type: EXPERIMENTAL
Intervention: drugs and acupuncture
Number of subjects: 143
Study: 3355041

Group type: EXPERIMENTAL
Intervention: Trimipramine
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 29859377

Group type: EXPERIMENTAL
Intervention: Patient Global Impression of Improvement (PGI-I)
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Clinician Global Impression Scale of Improvement (CGI-I)
Number of subjects: 472
Study: 28551645

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with 5‐fluorouracil, doxifluridine, or uracil‐tegafur for 12 months
Number of subjects: 229

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with uracil‐tegafur
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy for stage II disease
Number of subjects: 229
Study: 26170126

Group type: EXPERIMENTAL
Intervention: Aveeno® lotion
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Diprobase® cream
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Doublebase® gel
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Hydromol® ointment
Number of subjects: 160
Study: 23817921

Group type: EXPERIMENTAL
Intervention: Myelin peptide skin patch (1 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 21113833

Group type: EXPERIMENTAL
Intervention: Eight session protocol
Number of subjects: 137

Group type: COMPARATOR
Intervention: Four session protocol
Number of subjects: 137
Study: 18856126

Group type: EXPERIMENTAL
Intervention: Quantitative approach (randomized controlled clinical trial)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative approach
Number of subjects: 0
Study: 16801838

Group type: EXPERIMENTAL
Intervention: Generic prednisolone (15 mg/5 ml)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Orapred (15 mg/5 ml)
Number of subjects: 188
Study: 12970289

Group type: EXPERIMENTAL
Intervention: Synthetic human PTH-(1-34) (PTH)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Oral calcitriol and calcium
Number of subjects: 27